Although Chlamydia trachomatis occurs in all age groups and affects both men and women, it is most common in young women. The CDC estimates that 1 in 20 sexually active women aged 14-24 has chlamydia.

Chlamydia is the most common sexually transmitted infection (STI) worldwide. The form of the infection that affects humans is caused by a species of bacteria known as Chlamydia trachomatis.. The ...

Chlamydia is often asymptomatic. However, it can lead to infertility and other complications if left untreated. Getting tested is the only way to know your status.

Methods: Electronic databases and reference lists were searched from 2000 to 2013 using the key words "Chlamydia trachomatis", "population-based study" and "disease prevalence".Reference lists ...

Chlamydia can often go undetected in the human body, regardless of gender, which makes regular STI testing—and, potentially, a vaccine —a critically important tool to prevent the infection's ...

Causes: Pelvic inflammatory disease occurs when bacteria, often one called Chlamydia trachomatis, find their way through the vagina and the cervix (neck of the uterus) to the uterus, fallopian ...

Chlamydia trachomatis, the species of bacteria responsible for the STI, may hide out in our guts, according to a new study in the journal PLOS Pathogens.

Chlamydial conjunctivitis is a type of bacterial conjunctivitis that occurs as a result of the Chlamydia trachomatis bacteria. Learn more here.

Chlamydia is an infection caused by the bacterium Chlamydia trachomatis. It's one of the most widespread of all sexually transmitted diseases, according to the Centers for Disease Control and ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA ...

Sanofi’s chlamydia vaccine candidate was designed to protect against primary genital tract infection and reinfection by the bacterium Chlamydia trachomatis. The Food and Drug Administration (FDA ...